Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

BACKGROUND: Currently, it is not possible to predict whether patients with hyperuricemia (HUA) will develop gout and how this progression may be affected by urate-lowering treatment (ULT). Our study aimed to evaluate differences in plasma lipidome between patients with asymptomatic HUA detected ≤ 40...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvasnička, Aleš, Friedecký, David, Brumarová, Radana, Pavlíková, Markéta, Pavelcová, Kateřina, Mašínová, Jana, Hasíková, Lenka, Závada, Jakub, Pavelka, Karel, Ješina, Pavel, Stibůrková, Blanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693150/
https://www.ncbi.nlm.nih.gov/pubmed/38042879
http://dx.doi.org/10.1186/s13075-023-03204-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693150/
https://www.ncbi.nlm.nih.gov/pubmed/38042879
http://dx.doi.org/10.1186/s13075-023-03204-6

Ejemplares similares